Business
Anti-Pot Group Drops a Dime on Legalization Agreement – SAM Rats Out Wells Fargo’s Marijuana Tax Contract with Maryland
Conservative groups against marijuana legalization are snitching on financial agreements now
A group opposed to the legalization of marijuana is targeting a financial agreement between Wells Fargo and the state of Maryland. This arrangement enables state officials to collect and manage tax revenue from cannabis businesses operating legally within the state. The advocacy group is denouncing this arrangement as “a deliberate move to shield banks engaged in federal law violations” and is endeavoring to inform federal authorities about it. In response, the state maintains that it is “in adherence to relevant laws and regulations.”
Prohibitionist Groups’ Allegations
Smart Approaches to Marijuana (SAM), an organization opposing marijuana legalization, issued these allegations in a press release at the end of last month in response to media reports about the banking arrangement. The group also urged Wells Fargo to stop working with Maryland state officials to break federal laws and regulations in an open letter written to Maryland officials and Wells Fargo, along with copies to other federal officials. Erek L. Barron, the U.S. attorney for Maryland, would be in charge of any prospective federal charges in the state. Attorney General Merrick Garland and Treasury Secretary Janet Yellen were notable receivers of the letter.
In a prepared statement, SAM’s President and CEO, Kevin Sabet, expressed deep concern about the situation, describing it as “a slippery slope that should deeply trouble Marylanders.” He said, “By permitting banking access for marijuana revenues associated with a rising drug use and addiction crisis, Maryland is inadvertently enabling banks to profit from the sale of other illegal substances.”
Maryland’s Response and Wells Fargo’s Reply:
The catalyst for this dispute can be traced back to comments made in the previous month by Rob Scheerer, who serves as the director of the Maryland Office of the Comptroller’s Revenue Administration Division. Speaking at a conference attended by county government officials, Scheerer remarked that, to safeguard the interests of banks, they refrained from categorizing cannabis as such on tax returns. Instead, they employed a clever nomenclature, labeling it as ‘A sale subject to the 9 percent rate under Senate Bill 516 of 2023,’ a reference to the legislation that legalized and regulated marijuana sales in the state.
Following the publication of Scheerer’s comments, the state Comptroller’s Office issued the following statement via email:
“Under Maryland law, the Comptroller’s Office is in charge of collecting sales and use taxes on all taxable goods and services in the state, including adult-use cannabis, which was approved by the Maryland legislature in 2023 and passed by voters in a referendum in November 2022. These laws established the 9% sales and use tax on adult-use cannabis sales.
“Wells Fargo Bank provides lockbox and other treasury management services to the State of Maryland, including services related to collecting state tax revenue. State officials and Wells Fargo have taken all due care to ensure that the Maryland sales and use tax collection and the State’s handling of that tax revenue comply with applicable laws and regulations. Any inference or assertion that these processes have been designed to evade applicable laws or regulations is incorrect.”
Whether state officials have addressed SAM’s open letter remains to be seen. A spokesperson informed Marijuana Moment on Tuesday that the Comptroller’s Office had no further comments.
Regarding Wells Fargo, the company responded to SAM and Sabet’s letter last week, as relayed by spokesperson Gabriel Boehmer to Marijuana Moment. While the full correspondence was not disclosed, Boehmer shared an excerpt from the response:
“Recent media reports that we have been working with the State of Maryland to bank the marijuana industry are false,” it states. “We provide certain services to the State of Maryland related to the State’s tax revenue collection.”
The response also references the earlier statement from the Maryland comptroller’s office.
Federal Legislation and Next Steps:
As of Tuesday, SAM’s executive vice president informed Marijuana Moment that the organization had not yet received a response from Wells Fargo regarding its letter.
It’s important to clarify that neither Marijuana Moment nor Maryland Matters, the initial source of Scheerer’s comments on tax handling, reported that Wells Fargo was directly providing banking services to cannabis businesses themselves.
Due to marijuana’s continued federal illegality, banks and credit unions potentially face penalties from federal banking regulators when collaborating with cannabis businesses. According to the 1970 Banking Secrecy Act, funds linked to federally illegal activities must be reported through a suspicious activity report (SAR). When queried about whether Wells Fargo had submitted SARs concerning Maryland’s cannabis tax revenue, Boehmer declined to provide an official on-the-record response.
Federal legislators have been diligently addressing the banking challenges arising from the state-federal conflict on marijuana through the Secure and Fair Enforcement (SAFE) Banking Act, which was reintroduced in the current legislative session in April. If passed, this legislation would provide a secure haven for banks conducting business with the cannabis industry.
During a recent floor speech on Tuesday, Senate Majority Leader Chuck Schumer (D-NY) reaffirmed his commitment to advancing banking reform as the Senate resumed its session following the August recess. In a Dear Colleague letter circulated the previous week, Schumer highlighted “safeguarding cannabis banking” immediately after “lowering the cost of insulin and prescription drugs” as priorities.
The Senate Banking Committee’s markup is the next step in the marijuana banking bill’s development, and supporters and other interested parties hope it will happen soon.
The U.S. Department of Health and Human Services (HHS) is now suggesting that marijuana be moved from Schedule I to Schedule III under the Controlled Substances Act (CSA), which might give this proposal more support as lawmakers return to Capitol Hill. Such a change would make it possible for cannabis businesses with state licenses to deduct federal taxes.
Before the break in late July, Schumer held a press conference where he expressed optimism about the bill’s bipartisan talks and predicted a very active autumn Senate session. He underlined that the measure has constantly been his major priority, saying there is still a lot to be done by them upon their return.
Bottom Line
The clash between the anti-legalization group SAM, Wells Fargo, and Maryland officials underscores the ongoing complexities and legal ambiguities surrounding cannabis in the United States. While SAM raises concerns about potential federal law violations, Maryland maintains its adherence to applicable regulations. The push for federal banking reform through the SAFE Banking Act gains momentum as Senate Majority Leader Chuck Schumer reaffirms his commitment, and the recommendation by the U.S. Department of Health and Human Services to reschedule marijuana to a lower classification further supports this cause. As these discussions continue, the cannabis industry and its financial relationships remain in flux, awaiting potential legislative resolutions that could impact its future.
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy